Webinars
Below are our recent webinars.
Reducing Adverse Events After PCI: The Role of Genotype Antithrombotic Therapy Guidance
Featuring:
|
Prof Dr. Jur ten Berg, MD, PhD, MSc Department of Cardiology, St Antonius Hospital Nieuwegein the Netherlands And Maastricht University Medical Centre, Maastricht the Netherlands |
Assistant Professor Mattia Galli, MD, PhD FESC Assistant Professor of Cardiology, Sapienza University of Rome, Italy Interventional Cardiologist, Maria Cecilia Hospital – GVM Care & Research, Italy |
Learning Objectives:
- Introduction of pharmacogenetics: CYP2C19 Genotyping in optimization of antithrombotic therapy post PCI
- What’s the evidence of CYP2C19 Genotype-Guidance into DAPT De-escalation and escalation Strategies post PCI
- May 14, 2025
Reducing Recurrent Stroke Risk with CYP2C19 Genotype-Guided DAPT
Featuring:
Robert W. Regenhardt, MD, PhD
Vascular and Interventional Neurologist
UTHealth Houston
Learning Objectives:
•Understand the Role of Pharmacogenetics in Patient Response to Clopidogrel and its Impact in Dual Antiplatelet Therapy
Learn how CYP2C19 genotypes influence the efficacy and safety of dual antiplatelet therapy in stroke management and interventional neurology.
•Evaluate Clinical Evidence Supporting CYP2C19 Genotype-Guided Dual Antiplatelet Therapy
Review key clinical trial data and guidelines demonstrating the impact of tailoring antiplatelet therapy based on CYP2C19 genotype.
•Understand the Process of Implementing Rapid CYP2C19 Testing into Clinical Practice
Explore practical strategies for integrating rapid CYP2C19 genotyping into stroke care and interventional neurology workflows.
- January 22, 2025
